Concepedia

Mary Ayres

MA

Statistics

Publications

43

Citations

2.2K

H-Index

29

Active since

1966

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Northwestern University

The University of Texas Health Science Center at Houston

Robert H. Lurie Comprehensive Cancer Center of Northwestern University

Mary Ayres is an author at The University of Texas MD Anderson Cancer Center specializing in pharmacology, medicine, and oncology.

Publications per year

1966–2023

43

Publications

43

Comparison of Acalabrutinib, A Selective Bruton Tyrosine Kinase Inhibitor, with Ibrutinib in Chronic Lymphocytic Leukemia Cells

Viralkumar Patel, Kumudha Balakrishnan, Mary Ayres et al. · Clinical Cancer Research · 2016 · 146 citations · Full text

, , +14

Effects of NG-Methyl-L-arginine, NG-Nitro-L-arginine, and Aminoguanidine on Constitutive and Inducible Nitric Oxide Synthase in Rat Aorta

Ghislaine A. Joly, Mary Ayres, Frank D. Chelly et al. · Biochemical and Biophysical Research Communications · 1994 · 143 citations

, , +4

Intracellular Nucleotides Act as Critical Prosurvival Factors by Binding to Cytochrome C and Inhibiting Apoptosome

Dhyan Chandra, Shawn B. Bratton, Maria D. Person et al. · Cell · 2006 · 128 citations · Full text

, , +17

Compound GW506U78 in refractory hematologic malignancies: relationship between cellular pharmacokinetics and clinical response.

Varsha Gandhi, William Plunkett, Carlos O. Rodriguez et al. · Journal of Clinical Oncology · 1998 · 107 citations

, , +15

A proof-of-principle pharmacokinetic, pharmacodynamic, and clinical study with purine nucleoside phosphorylase inhibitor immucillin-H (BCX-1777, forodesine)

Varsha Gandhi, John Michael Kilpatrick, William Plunkett et al. · Blood · 2005 · 100 citations · Full text

, , +12

1–5 of 43